Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19
Clinical trial NCT05679479 · COMPLETED
Trial details
- NCT number
- NCT05679479
- Sponsor
- Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-19
- Primary completion
- 2024-01-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.